Cost-Benefit Model System of Chronic Diseases in Australia to Assess and Rank Prevention and Treatment Options

Agnes E. Walker () and Stephen Colagiuri ()
Additional contact information
Agnes E. Walker: Australian National University, Canberra 0200, Australia
Stephen Colagiuri: University of Sydney, Sydney NSW 2006, Australia;

International Journal of Microsimulation, 2011, vol. 4, issue 3, 57-70

Abstract: Chronic diseases - eg heart disease, cancer, diabetes, mental disorders - affect around 80% of older Australians, are the main causes of disability and premature death, and account for 70% of total health expenditures. Because lifestyle patterns are major risk factors, chronic disease prevention and treatment are not only of medical concern, but also of considerable social, family-level and personal interest. While this makes microsimulation approaches particularly suitable for assessing intervention costs and benefits, such approaches will need to be combined with disease-progression models if health status and treatment choices are also to be simulated. AIMS: Describe methodological and technical proposals for the development of a cost-benefit model-system. METHODS: Several chronic disease progression models are to be linked to an Umbrella microsimulation model representing the Australian population. To project 20 years ahead, use of reweighting techniques are proposed for population projections, disease-specific predictions and for health-related projections. The model-system is to account simultaneously for Australians demographic, socioeconomic and health-risk-factor characteristics; progression of their health status; the number of chronic diseases (comorbidities) they accumulate over time; health-related expenditures; and changes in quality of life. Standard methods are proposed to estimate costs versus benefits of simulated policy interventions and related quality of life improvements. KEY OUTCOME: Proposal of novel methods for modelling comorbidities - a task rarely attempted, although quality of life is known to decline and health expenditures to increase well above what a linear addition of the effects of individual chronic diseases would predict.

Keywords: Chronic Disease; Comorbidities; Cost-Benefit Model; Australia (search for similar items in EconPapers)
Date: 2011
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://ima.natsem.canberra.edu.au/IJM/V4_3/Walker%20Paper%20v3.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ijm:journl:v:4:y:2011:i:3:p:57-70

Access Statistics for this article

International Journal of Microsimulation is currently edited by Matteo Richiardi

More articles in International Journal of Microsimulation from International Microsimulation Association
Bibliographic data for series maintained by Jinjing Li ().